GMGEX vs. GIOTX

Last updated Jun 5, 2026

GMGEX (GMO Global Equity Allocation Fund) and GIOTX (GMO International Developed Equity Allocation Fund) are both mutual funds - GMGEX is a Global Equities fund managed by GMO, while GIOTX is a Foreign Large Cap Equities fund managed by GMO. Over the past 10 years, GMGEX returned 11.28%/yr vs 11.92%/yr for GIOTX. Their correlation of 0.94 suggests significant overlap in exposure. GMGEX charges 0.01%/yr vs 0.00%/yr for GIOTX.

Performance

GMGEX vs. GIOTX - Performance Comparison

The chart below illustrates the hypothetical performance of a $10,000 investment in GMO Global Equity Allocation Fund (GMGEX) and GMO International Developed Equity Allocation Fund (GIOTX). The values are adjusted to include any dividend payments, if applicable.

Returns By Period

The year-to-date returns for both stocks are quite close, with GMGEX having a 19.27% return and GIOTX slightly lower at 18.54%. Over the past 10 years, GMGEX has underperformed GIOTX with an annualized return of 11.28%, while GIOTX has yielded a comparatively higher 11.92% annualized return.

GMGEX

• 1D: -0.48%
• 1M: 4.86%
• YTD: 19.27%
• 6M: 21.08%
• 1Y: 41.55%
• 3Y*: 21.78%
• 5Y*: 9.85%
• 10Y*: 11.28%

GIOTX

• 1D: -0.26%
• 1M: 4.51%
• YTD: 18.54%
• 6M: 21.26%
• 1Y: 41.73%
• 3Y*: 28.31%
• 5Y*: 13.79%
• 10Y*: 11.92%

*Multi-year figures are annualized to reflect compound growth (CAGR)

GMGEX vs. GIOTX - Yearly Performance Comparison

	2026 (YTD)	2025	2024	2023	2022	2021	2020	2019	2018	2017
GMGEX GMO Global Equity Allocation Fund	19.27%	29.14%	4.12%	22.27%	-17.07%	14.99%	9.55%	25.45%	-13.04%	26.39%
GIOTX GMO International Developed Equity Allocation Fund	18.54%	43.70%	10.66%	21.03%	-12.41%	11.14%	7.43%	24.45%	-19.66%	26.38%

Correlation

The correlation between GMGEX and GIOTX is 0.93, indicating a strong positive relationship between their price movements. Combining them offers limited diversification - they tend to fall together during downturns.

	Correlation
Correlation (1Y) Calculated over the trailing 1-year period	0.93
Correlation (3Y) Calculated over the trailing 3-year period	0.91
Correlation (5Y) Calculated over the trailing 5-year period	0.92
Correlation (10Y) Calculated over the trailing 10-year period	0.94
Correlation (All Time) Calculated using the full available price history since Jan 4, 2007	0.94

The correlation between GMGEX and GIOTX has been stable across timeframes, ranging from 0.91 to 0.94 - a consistent structural relationship.

Return for Risk

GMGEX vs. GIOTX — Risk / Return Rank

Compare risk-adjusted metric ranks to identify better-performing investments over the past 12 months.

GMGEX

GMGEX Risk / Return Rank: 90
GMGEX Sharpe Ratio Rank: 94
GMGEX Sortino Ratio Rank: 91
GMGEX Omega Ratio Rank: 86
GMGEX Calmar Ratio Rank: 90
GMGEX Martin Ratio Rank: 90

GIOTX

GIOTX Risk / Return Rank: 82
GIOTX Sharpe Ratio Rank: 86
GIOTX Sortino Ratio Rank: 80
GIOTX Omega Ratio Rank: 78
GIOTX Calmar Ratio Rank: 85
GIOTX Martin Ratio Rank: 85

The rank (0–100) shows how this investment's returns compare to the risk taken. Higher = better. Based on the past 12 months of data, combining Sharpe, Sortino, and other metrics used by quantitative funds and institutional investors.

GMGEX vs. GIOTX - Risk-Adjusted Trends Comparison

This table presents a comparison of risk-adjusted performance metrics for GMO Global Equity Allocation Fund (GMGEX) and GMO International Developed Equity Allocation Fund (GIOTX). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.

	GMGEX	GIOTX	Difference
Sharpe ratio: Return per unit of total volatility	3.31	2.78	+0.53
Sortino ratio: Return per unit of downside risk	4.53	3.83	+0.69
Omega ratio: Gain probability vs. loss probability	1.60	1.51	+0.10
Calmar ratio: Return relative to maximum drawdown	4.54	3.97	+0.57
Martin ratio: Return relative to average drawdown	18.01	15.62	+2.40
Data is calculated on a 1-year rolling basis and updated daily. The trend shows the change in the indicator over the past month.

GMGEX vs. GIOTX - Sharpe Ratio Comparison

The current GMGEX Sharpe Ratio is 3.31, which is comparable to the GIOTX Sharpe Ratio of 2.78. The chart below compares the historical Sharpe Ratios of GMGEX and GIOTX, calculated using daily returns over the previous 12 months. A higher Sharpe Ratio indicates better risk-adjusted performance relative to the risk-free rate.

Sharpe Ratios by Period

	GMGEX	GIOTX	Difference
Sharpe Ratio (1Y) Calculated over the trailing 1-year period	3.31	2.78	+0.53
Sharpe Ratio (5Y) Calculated over the trailing 5-year period	0.67	0.90	-0.23
Sharpe Ratio (10Y) Calculated over the trailing 10-year period	0.70	0.73	-0.03
Sharpe Ratio (All Time) Calculated using the full available price history	0.25	0.34	-0.09

Drawdowns

GMGEX vs. GIOTX - Drawdown Comparison

The maximum GMGEX drawdown since its inception was -58.47%, roughly equal to the maximum GIOTX drawdown of -56.51%. Use the drawdown chart below to compare losses from any high point for GMGEX and GIOTX.

Drawdown Indicators

	GMGEX	GIOTX	Difference
Max Drawdown Largest peak-to-trough decline	-58.47%	-56.51%	-1.96%
Max Drawdown (1Y) Largest decline over 1 year	-9.24%	-10.66%	+1.42%
Max Drawdown (3Y) Largest decline over 3 years	-17.12%	-13.40%	-3.72%
Max Drawdown (5Y) Largest decline over 5 years	-28.58%	-29.68%	+1.10%
Max Drawdown (10Y) Largest decline over 10 years	-34.98%	-39.29%	+4.31%
Current Drawdown Current decline from peak	-0.48%	-0.26%	-0.22%
Average Drawdown Average peak-to-trough decline	-16.75%	-14.24%	-2.51%
Ulcer Index Depth and duration of drawdowns from previous peaks	2.32%	2.70%	-0.38%

Volatility

GMGEX vs. GIOTX - Volatility Comparison

The current volatility for GMO Global Equity Allocation Fund (GMGEX) is 4.01%, while GMO International Developed Equity Allocation Fund (GIOTX) has a volatility of 4.40%. This indicates that GMGEX experiences smaller price fluctuations and is considered to be less risky than GIOTX based on this measure. The chart below showcases a comparison of their rolling one-month volatility.

Volatility by Period

	GMGEX	GIOTX	Difference
Volatility (1M) Calculated over the trailing 1-month period	4.01%	4.40%	-0.39%
Volatility (6M) Calculated over the trailing 6-month period	9.91%	11.99%	-2.08%
Volatility (1Y) Calculated over the trailing 1-year period	12.66%	15.22%	-2.56%
Volatility (5Y) Calculated over the trailing 5-year period, annualized	14.81%	15.39%	-0.58%
Volatility (10Y) Calculated over the trailing 10-year period, annualized	16.06%	16.34%	-0.28%

GMGEX vs. GIOTX - Expense Ratio Comparison

GMGEX has a 0.01% expense ratio, which is higher than GIOTX's 0.00% expense ratio. However, both funds are considered low-cost compared to the broader market, where average expense ratios usually range from 0.3% to 0.9%.

Dividends

GMGEX vs. GIOTX - Dividend Comparison

GMGEX's dividend yield for the trailing twelve months is around 3.93%, less than GIOTX's 6.78% yield.

Position	TTM	2025	2024	2023	2022	2021	2020	2019	2018	2017	2016	2015
GIOTX GMO International Developed Equity Allocation Fund	6.78%	8.04%	5.07%	6.54%	4.45%	6.67%	4.48%	3.74%	3.90%	3.15%	4.04%	3.39%
GMGEX GMO Global Equity Allocation Fund	3.93%	4.69%	0.29%	5.62%	7.81%	7.76%	3.83%	3.14%	3.14%	2.90%	3.71%	4.20%

Frequently Asked Questions

Can I hold both GMGEX and GIOTX in my portfolio?

With a correlation of 0.93, GMGEX and GIOTX move almost identically. Holding both adds very little diversification - you're essentially doubling your position in the same market segment. Choosing one is usually more capital-efficient.

Which is riskier, GMGEX or GIOTX?

GIOTX has higher volatility (4.40%) compared to GMGEX (4.01%). In terms of maximum drawdown, GMGEX dropped -58.47% vs GIOTX's -56.51%.

Which has better risk-adjusted returns?

GMGEX currently has the higher Sharpe Ratio (3.31 vs 2.78), meaning it's delivered slightly more return per unit of risk over the trailing 12 months. However, this ranking shifts over time - use the Risk/Return Score above for a more comprehensive view that combines Sharpe, Sortino, and other measures used by quantitative funds.